These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 8709780)

  • 1. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
    G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy).
    Palareti G; Manotti C; DAngelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Leali N; Poggi M; Legnani C; Musolesi S; Coccheri S
    Thromb Haemost; 1997 Dec; 78(6):1438-43. PubMed ID: 9423791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.
    Palareti G; Hirsh J; Legnani C; Manotti C; D'Angelo A; Pengo V; Moia M; Guazzaloca G; Musolesi S; Coccheri S
    Arch Intern Med; 2000 Feb; 160(4):470-8. PubMed ID: 10695687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Major closed-space bleeding in patients on anticoagulation with acenocoumarol (TAO) or non-fractionned heparin(HS): a case-control study].
    Martínez Lacasa J; Juan N; Juliá J; Rodríguez-Carballeira M; de Diego I; Soto R; Garau J
    An Med Interna; 2008 Jan; 25(1):9-14. PubMed ID: 18377188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of factors responsible for oral over-anticoagulation in outpatients with heart disease].
    Freixa R; Blanch P; Ibernón M; Padró J; Delso J; Sobrepera JL; Salas E; Dos L; Codinach P
    Rev Esp Cardiol; 2003 Jan; 56(1):65-72. PubMed ID: 12550002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Boddi V; Gensini GF; Abbate R; Prisco D
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):269-75. PubMed ID: 12695750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
    Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
    Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago.
    Palareti G; Antonucci E; Migliaccio L; Erba N; Marongiu F; Pengo V; Poli D; Testa S; Tosetto A; Tripodi A; Moia M;
    Intern Emerg Med; 2017 Dec; 12(8):1109-1119. PubMed ID: 28501909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group.
    Schulman S
    J Intern Med; 1994 Aug; 236(2):143-52. PubMed ID: 8046313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Thromb Haemost; 2004 Jul; 92(1):61-6. PubMed ID: 15213846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.